Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NTAP vs GSK✓SelectedUSD · GSKNTAP vs GSK performance historyLatest closeAs of-2.70%11/17
Stock and ETF performance explorer

NTAP vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+135.6%
GSK return
+58.9%
Excess return
+76.8%
Maximum drawdown
-42.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.7%-2.3%-0.4%-2.8%
7D-1.7%-3.0%+1.3%-1.8%
30D-15.1%+0.4%-15.4%-15.0%
3M-15.1%-1.2%-13.9%-14.9%
6M+45.0%+0.9%+44.1%+45.0%
YTD+64.1%+4.0%+60.1%+63.7%
1Y+64.5%+7.3%+57.2%+64.0%
3Y+135.6%+57.1%+78.6%+141.8%
All+135.6%+58.9%+76.8%+141.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling